ArticleCancer research and treatment2019

Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology.

Hyerim Ha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.